Dr. Z.A. Schreiber, Department of Medicine, Bronx-Lebanon Hospital, 1650 Grand Concourse, Bronx, NY 10457 (USA) Dear Sir, Acute renal failure in multiple myeloma patients is uncommon [1, 2]. It is usually precipitated by hypercal-cemia, infection associated with volume depletion or the administration of potentially nephrotoxic antibiotics. In a rare instance, intravascular injection of iodine-containing contrast dyes had led to acute renal failure [3–5]. We report here a patient with multiple myeloma who developed acute renal failure after a single oral dose of 3 g of iopanoic acid (Telepaque) as a contrast agent for cholecystography. Case Report R.B., a 66-year old woman was admitted because of oliguria of 1 day duration. Two days before admission, she ingested 3 g of iopanoic acid. She had a long history of hypertension and osteoarthritis for which she was on Minipress, Lopressor, Dyazide and Motrin. Two months earlier, blood tests revealed normal renal function. On admission, she was pale, hypertensive without evidence of congestive heart failure or dehydration. Her urine output in the first 24 h was 1,500 ml, progressively decreasing to 50 ml on the 27th day of the hospital stay. On admission, the serum creatinine was 8.0 mg%, BUN 58 mg%, calcium 9.0 mg%, phosphate 6.4 mg%, uric acid 11.4 mg%. She also had a normochromic normocytic anemia with a hematocrit of 27%. Urinalysis revealed marked proteinuria which varied between 2.0 and 4.4 g/day, a few red cells, but no casts. Urine immunoelectrophoresis revealed a large amount of free λ-chains, and serum immunoelectrophoresis revealed a small monoclonal IgA λ spike. A sternal bone marrow showed complete bone marrow replacement by plasma cells. In spite of chemotherapy and hemodialysis, she did not recover renal function and expired 6 months later from progressive myeloma. Progressive chronic renal failure in multiple myeloma patients is common and occurs at some time during this illness in about half of the patients [1, 3–5]. In contrast, acute renal failure without preceding renal impairment is not common, occurring in only 8.7% of the patients reported in a recent series [2]. Earlier reports emphasized the role of intravenous pyelography in precipitating acute renal failure, but this incidence is probably low [1,2]. Acute renal failure after oral cholecystography with iopanoic acid (Telepaque) is rare and was reported to occur only after administration of a larger than usual dose [6–10]. Thus, our patient with multiple myeloma is unique in developing acute renal failure after a single oral dose of 3 g of iopanoic acid, whereas, the 9 previously reported patients were given between 6 and 15 g of iopanoic acid. The patient reported here never recovered renal function in contrast to the other 9 reported patients [6–10]. The probable cause of acute renal failure induced by iodinated radio-contrast dyes is intraluminal
[1]
G. Appel,et al.
Acute Renal Failure in Patients With Multiple Myeloma
,
1984
.
[2]
L. Byrd,et al.
Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review.
,
1979,
Medicine.
[3]
R. DeFronzo,et al.
ACUTE RENAL FAILURE IN MULTIPLE MYELOMA
,
1975,
Medicine.
[4]
G. H. Myers,et al.
Acute renal failure after excretory urography in multiple myeloma.
,
1971,
The American journal of roentgenology, radium therapy, and nuclear medicine.
[5]
G. H. Smith,et al.
Brief recordings. Acute renal failure after the administration of iopanoic acid as a cholecystographic agent.
,
1969,
The New England journal of medicine.
[6]
W. Waugh,et al.
FACTORS IN THE RENAL FAILURE OF MULTIPLE MYELOMA.
,
1965,
Archives of internal medicine.
[7]
S. Mellinkoff,et al.
Renal insufficiency after oral administration of a double dose of a cholecystographic medium: report of two cases.
,
1959,
The New England journal of medicine.
[8]
H. Conn,et al.
Acute renal failure after intravenous pyelography in plasma cell myeloma.
,
1958,
Journal of the American Medical Association.